Stocks and Investing Stocks and Investing
Thu, April 18, 2024

Shagun Singh Maintained (ABT) at Buy with Decreased Target to $125 on, Apr 18th, 2024


Published on 2024-10-28 10:27:20 - WOPRAI, Shagun Singh
  Print publication without navigation


Shagun Singh of RBC Capital, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $128 to $125 on, Apr 18th, 2024.

Shagun has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 0 agree with Shagun's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Shagun


  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Increased Target to $125 on, Thursday, April 4th, 2024
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $128 on, Wednesday, April 3rd, 2024
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $141 on, Friday, January 26th, 2024
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $127 on, Thursday, January 25th, 2024
Contributing Sources